Streetbeat News

Earnings

INVO

INVO Bioscience reported Q2 losses of $(3.06) per share, beating the analyst consensus estimate of $(4.20) by 27.14%. However, the company's quarterly sales of $315.90K missed the analyst consensus estimate of $2.96M by 89.33%. This represents a 1230.43% increase in losses and a 116.17% increase in sales compared to the same period last year.

Portfolio Pulse from totan@benzinga.com

August 14, 2023 | 8:08 pm

XP

XP Inc. reported a 21% YoY increase in total client assets for Q2. However, the total net inflow was down by 49%.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:07 pm

SLGC

SomaLogic (NASDAQ:SLGC) reported Q2 earnings per share of $(0.13), beating the analyst consensus estimate of $(0.16) by 18.75%. The company's quarterly sales were $20.47 million, surpassing the analyst consensus estimate of $19.82 million by 3.27%. This represents a 44.71% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:07 pm

VTSI

VirTra reported Q2 earnings of $0.09 per share, beating the analyst consensus estimate of $0.08 by 12.5%. The company also reported quarterly sales of $10.30 million, surpassing the analyst consensus estimate of $7.99 million by 28.91%. Both earnings and sales have increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:06 pm

NOGN

Nogin (NASDAQ:NOGN) reported Q2 losses of $(1.13) per share, missing the analyst consensus estimate of $(0.90) by 25.56 percent. The company also reported quarterly sales of $12.70 million, missing the analyst consensus estimate of $14.94 million by 14.99 percent.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:06 pm

TOMZ

TOMI Environmental Solns (NASDAQ:TOMZ) reported Q2 sales of $2.77 million, missing the analyst consensus estimate of $4.04 million by 31.32 percent. However, this is a 90.31 percent increase over sales of $1.46 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:06 pm

NVTS

Navitas Semiconductor (NASDAQ:NVTS) reported Q2 adjusted losses of $(0.05) per share, beating the analyst consensus estimate of $(0.07) by 28.57%. The company also reported quarterly sales of $18.06 million, surpassing the analyst consensus estimate of $16.50 million by 9.47%. This represents a 109.75% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:06 pm

DUOT

Duos Technologies Group reported Q2 losses of $(0.42) per share, missing the analyst consensus estimate of $(0.25) by 68%. This is a 90.91% decrease from the same period last year. The company also reported quarterly sales of $1.77 million, missing the analyst consensus estimate of $2.65 million by 33.21%. This is a 51.06% decrease from the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 14, 2023 | 8:05 pm

DLPN

Dolphin Entertainment reported Q2 losses of $(0.60) per share, a significant increase from $(0.01) loss per share from the same period last year. However, the company's quarterly sales of $11.02 million beat the analyst consensus estimate of $10.74 million by 2.64 percent, marking a 7.12 percent increase over sales of $10.29 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:04 pm

NMTC

NeuroOne Medical Tech (NASDAQ:NMTC) reported Q3 losses of $(0.20) per share, a 17.65% decrease YoY. However, the company's sales increased by 1.87K% to $629.91K from $32.05K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 8:04 pm